An assay was described for measures of adducts of styrene oxide (SO) with molecules of hemoglobin(Hb) which have been modified at residues containing either carboxylic acid or sulfhydryl groups. The method employs tw...An assay was described for measures of adducts of styrene oxide (SO) with molecules of hemoglobin(Hb) which have been modified at residues containing either carboxylic acid or sulfhydryl groups. The method employs two steps. In the first, SO carboxylic acid adducts are hydrolyzed in basic medium to liberate styrene glycol(SG). Then, the remaining residues are reacted with a reductive catalyst (Raney nickel) to liberate the two positional isomers of SO cysteine adducts, i.e., 1 phenylethanol (1 PE) and 2 phenylethanol (2 PE). The liberated products are derivatized with pentafluorobenzoyl chloride and measured by GC NICI MS. The assay was evaluated with SO adducts of Hb which had been produced in the blood of Sprague Dawley rats following (a) in vitro modification(0—300m mol/L SO) or (b) i.p administration of either SO(0—1 mmol/kg) or styrene (0—3 mmol/kg). Levels of each of the three analytes (SG, 1 PE, and 2 PE) increased with dose in hemoglobin. The ratios of cysteine adducts to carboxylic acid adducts varied significantly among experiments. Ratios of 2 PE to 1 PE were much more consistent (2 PE/1 PE=6.9 (SE=1.5)) suggesting that binding of SO to cysteine residues of blood proteins is greatly preferred at the α position rather than the β position both in vitro and in vivo. The lowest detectable adduct concentration, using 10 mg of protein, was 8 pmol/g protein for SG,5 pmol/g protein for 1 PE, and 0.6 pmol/g protein for 2 PE. No significant change of adduct level was found during storage of proteins at -80℃ for 1 year.展开更多
文摘An assay was described for measures of adducts of styrene oxide (SO) with molecules of hemoglobin(Hb) which have been modified at residues containing either carboxylic acid or sulfhydryl groups. The method employs two steps. In the first, SO carboxylic acid adducts are hydrolyzed in basic medium to liberate styrene glycol(SG). Then, the remaining residues are reacted with a reductive catalyst (Raney nickel) to liberate the two positional isomers of SO cysteine adducts, i.e., 1 phenylethanol (1 PE) and 2 phenylethanol (2 PE). The liberated products are derivatized with pentafluorobenzoyl chloride and measured by GC NICI MS. The assay was evaluated with SO adducts of Hb which had been produced in the blood of Sprague Dawley rats following (a) in vitro modification(0—300m mol/L SO) or (b) i.p administration of either SO(0—1 mmol/kg) or styrene (0—3 mmol/kg). Levels of each of the three analytes (SG, 1 PE, and 2 PE) increased with dose in hemoglobin. The ratios of cysteine adducts to carboxylic acid adducts varied significantly among experiments. Ratios of 2 PE to 1 PE were much more consistent (2 PE/1 PE=6.9 (SE=1.5)) suggesting that binding of SO to cysteine residues of blood proteins is greatly preferred at the α position rather than the β position both in vitro and in vivo. The lowest detectable adduct concentration, using 10 mg of protein, was 8 pmol/g protein for SG,5 pmol/g protein for 1 PE, and 0.6 pmol/g protein for 2 PE. No significant change of adduct level was found during storage of proteins at -80℃ for 1 year.
